FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1268682007: Product containing only lamivudine and tenofovir in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5180718017 Lamivudine and tenofovir only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5180719013 Product containing only lamivudine and tenofovir in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5980881000052111 läkemedel som endast innehåller lamivudin och tenofovir, oral läkemedelsform sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine and tenofovir only product in oral dose form Is a Lamivudine- and tenofovir-containing product in oral dose form true Inferred relationship Some
Lamivudine and tenofovir only product in oral dose form Is a Lamivudine and tenofovir only product true Inferred relationship Some
Lamivudine and tenofovir only product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Some
Lamivudine and tenofovir only product in oral dose form Plays role Antiretroviral therapeutic role true Inferred relationship Some
Lamivudine and tenofovir only product in oral dose form Has active ingredient Lamivudine (substance) true Inferred relationship Some 1
Lamivudine and tenofovir only product in oral dose form Has active ingredient Tenofovir (substance) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely lamivudine 300 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) Is a True Lamivudine and tenofovir only product in oral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start